Shandong Jincheng Pharmaceutical Group Co Ltd
300233
Company Profile
Business description
Shandong Jincheng Pharmaceutical Group Co Ltd is engaged in the research and development, production and sale of III and IV cephalosporin intermediates and biopharmaceuticals. It offers characteristic bulk drugs, pharmaceutical intermediates, and fine chemicals. The company distributes its products within domestic market and to overseas markets.
Contact
No. 1 Shuangshan Road
Zichuan Economic Development Zone
Shandong
Zibo255100
CHNT: +86 5335439432
Sector
Basic Materials
Stock type
Cyclical
Industry
Chemicals
Fiscal Year End
31 December 2026
Employees
3,515
Stocks News & Analysis
stocks
Going into earnings, is Alphabet stock a buy, a sell, or fairly valued?
From AI integration to capital expenditure increases, here’s what we expect in Alphabet’s earnings report.
stocks
ASX energy share remains cheap despite strong outlook
Santos reports a solid quarter on the back of higher commodity prices - yet the shares look undervalued.
stocks
Moated AI-proof tech play hiding in the ASX 100
ChatGPT and large language models should be a tailwind for this company.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,006.40 | 19.00 | -0.21% |
| CAC 40 | 8,171.55 | 55.77 | -0.68% |
| DAX 40 | 24,163.38 | 7.93 | 0.03% |
| Dow JONES (US) | 49,166.09 | 144.23 | -0.29% |
| FTSE 100 | 10,407.35 | 49.66 | -0.47% |
| HKSE | 25,978.07 | 62.87 | 0.24% |
| NASDAQ | 24,623.61 | 185.10 | 0.76% |
| Nikkei 225 | 59,716.18 | 575.95 | 0.97% |
| NZX 50 Index | 12,874.94 | 9.99 | -0.08% |
| S&P 500 | 7,130.19 | 21.79 | 0.31% |
| S&P/ASX 200 | 8,786.50 | 12.10 | -0.14% |
| SSE Composite Index | 4,079.90 | 13.35 | -0.33% |